CL
CCXI

CSS LLC’s ChemoCentryx, Inc. CCXI Stock Holding History

CSS LLC’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-78,100
Closed -$1.33M – 1467
2021
Q3 		$1.33M Buy
78,100
+12,200
+19% +$190K 0.06% 344
2021
Q2 		$883K Buy
+65,900
New +$1.62M 0.04% 441
2020
Q4 		– Sell
-600
Closed -$33K – 989
2020
Q3 		$33K Buy
+600
New +$32.3K ﹤0.01% 731

Other funds holding CCXI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

CSS LLC's CCXI Position: Q3 2022 in Review

CSS LLC sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 12,912 shares — an estimated $320K sold.

CSS LLC first reported a position in CCXI in Q3 2020 and held it in 6 quarters. The position peaked at $874K in Q3 2021. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.

  • CSS LLC reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
  • CSS LLC sold 12,912 ChemoCentryx, Inc. shares in Q3 2022, an estimated $320K.
  • CSS LLC first reported a position in ChemoCentryx, Inc. in Q3 2020 and held it in 6 quarters.
  • CSS LLC's ChemoCentryx, Inc. position peaked at $874K in Q3 2021.
  • 217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.

Based on CSS LLC's 13F filing for Q3 2022, filed 14 Nov 2022.